Active ingredientPrimidoneCat. No. P-P190-001CAS 125-33-7Family · Pharmaceutical analytical standards
Primidone
An anticonvulsant related to the barbiturates: its efficacy was shown in 1949 by Yule Bogue and in 1950 it came onto the market in the United Kingdom and Germany; today it is also used for essential tremor. This family brings together the active ingredient, pharmacopoeial impurities and labelled standards.
Did you know?In the body it is partly converted into phenobarbital, another anticonvulsant; its effect on essential tremor was reported in 1981, starting from the observation of a single patient.
Go to the active ingredient →Active ingredientPrimidoneCat. No. P-P190-001CAS 125-33-7
Pharmacopoeial impurityPrimidone EP Impurity A (as Hydrate)Cat. No. P-P190-002CAS 80866-90-6
Pharmacopoeial impurityPrimidone EP Impurity CCat. No. P-P190-003CAS 90-26-6
Pharmacopoeial impurityPrimidone EP Impurity DCat. No. P-P190-004CAS 80544-75-8
Pharmacopoeial impurityPrimidone EP Impurity ECat. No. P-P190-005CAS 90-27-7
Pharmacopoeial impurityPrimidone EP Impurity FCat. No. P-P190-006CAS 1189504-46-8
Pharmacopoeial impurityPrimidone USP Related Compound ACat. No. P-P190-007CAS 7206-76-0
Isotopically labelledPrimidone-d5Cat. No. P-P190-008CAS 73738-06-4No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substancePrimidone CRSEDQM code P2950000Family PrimidoneNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.